ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy

Harwood, SLAlvarez-Cienfuegos, ANunez-Prado, NCompte, MHernandez-Perez, SMerino, NBonet, JNavarro, RHenegouwen, PMPVELykkemark, SMikkelsen, KMolgaard, KJabs, FSanz, LBlanco, FJRoda-Navarro, PAlvarez-Vallina, L2018-11-082018-11-082018-11-08201810.1080/2162402X.2017.1377874https://infoscience.epfl.ch/handle/20.500.14299/149895WOS:000424080200026ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapytext::journal::journal article::research article